Correction: Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma

Correction: Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma

Show other versions (1)

Bibliographic Details
Main Authors:	Erik Koehne, Nina Zander, Miriam Rodi, Jana Held, Wolfgang Hoffmann, Rella Zoleko-Manego, Michael Ramharter, Ghyslain Mombo-Ngoma, Peter G. Kremsner, Andrea Kreidenweiss
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2022-06-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162304/?tool=EBI

Similar Items

Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma.
by: Erik Koehne, et al.
Published: (2021-06-01)

Correction: Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma.
by: Erik Koehne, et al.
Published: (2022-06-01)

Description of Plasmodium falciparum infections in central Gabon demonstrating high parasite densities among symptomatic adolescents and adults
by: Rella Zoleko Manego, et al.
Published: (2019-11-01)

Erratum to ‘In vitro activity of eravacycline, a novel synthetic halogenated tetracycline, against the malaria parasite Plasmodium falciparum’ [Journal of Global Antimicrobial Resistance 24 (2021) 93-97]
by: Erik Koehne, et al.
Published: (2022-12-01)

In vitro activity of eravacycline, a novel synthetic halogenated tetracycline, against the malaria parasite Plasmodium falciparum
by: Erik Koehne, et al.
Published: (2021-03-01)

Genetic diversity of Plasmodium malariae in sub-Saharan Africa: a two-marker genotyping approach for molecular epidemiological studies
by: Miriam Rodi, et al.
Published: (2024-07-01)

Effectiveness of antimalarial drug combinations in treating concomitant urogenital schistosomiasis in malaria patients in Lambaréné, Gabon: A non-randomised event-monitoring study.
by: Rella Zoleko-Manego, et al.
Published: (2022-10-01)

DNA recovery from archived RDTs for genetic characterization of Plasmodium falciparum in a routine setting in Lambaréné, Gabon
by: The Trong Nguyen, et al.
Published: (2019-10-01)

Undiagnosed AIDS in a 13-year-old boy in rural Gabon
by: Saskia Dede Davi, et al.
Published: (2024-01-01)

Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection.
by: Thomas R Lane, et al.
Published: (2019-11-01)

Loa loa Infection in Pregnant Women, Gabon
by: Ghyslain Mombo-Ngoma, et al.
Published: (2015-05-01)

<it>In vitro </it>activity of pyronaridine against <it>Plasmodium falciparum </it>and comparative evaluation of anti-malarial drug susceptibility assays
by: Pongratz Peter, et al.
Published: (2009-04-01)

Anti-bacterial activity of intermittent preventive treatment of malaria in pregnancy: comparative <it>in vitro </it>study of sulphadoxine-pyrimethamine, mefloquine, and azithromycin
by: Mombo-Ngoma Ghyslain, et al.
Published: (2010-10-01)

Pyronaridine-artesunate real-world safety, tolerability, and effectiveness in malaria patients in 5 African countries: A single-arm, open-label, cohort event monitoring study.
by: Gaston Tona Lutete, et al.
Published: (2021-06-01)

Epidemiology of co-infections in pregnant women living with human immunodeficiency virus 1 in rural Gabon: a cross-sectional study
by: Saskia Dede Davi, et al.
Published: (2023-07-01)

Evaluation of knowledge, attitude and practices towards loiasis in the rural community of Sindara, in central African Gabon.
by: Teite Rebecca Hildebrandt, et al.
Published: (2024-05-01)

Birth weight, growth, nutritional status and mortality of infants from Lambaréné and Fougamou in Gabon in their first year of life.
by: Rella Zoleko-Manego, et al.
Published: (2021-01-01)

Assessing the Incidence of Snakebites in Rural Gabon—A Community-Based, Cross-Sectional Pilot Survey
by: Saskia Dede Davi, et al.
Published: (2024-03-01)

Species and genotype diversity of Plasmodium in malaria patients from Gabon analysed by next generation sequencing
by: Albert Lalremruata, et al.
Published: (2017-10-01)

Distinct loiasis infection states and associated clinical and hematological manifestations in patients from Gabon.
by: Luzia Veletzky, et al.
Published: (2022-09-01)

Epidemiology of Human Herpes Virus 8 in Pregnant Women and their Newborns - A cross-sectional delivery survey in Central Gabon
by: Mesküre Capan-Melser, et al.
Published: (2015-10-01)

Real-life effectiveness of anti-malarial treatment regimens: what are we aiming for?
by: Dorothea Ekoka Mbassi, et al.
Published: (2023-06-01)

Reported healthcare-seeking of loiasis patients and estimation of the associated monetary burden in Gabon: Data from a cross-sectional survey.
by: Luzia Veletzky, et al.
Published: (2024-08-01)

Efficacy and safety of ivermectin for the treatment of Plasmodium falciparum infections in asymptomatic male and female Gabonese adults – a pilot randomized, double-blind, placebo-controlled single-centre phase Ib/IIa clinical trialResearch in context
by: Dorothea Ekoka Mbassi, et al.
Published: (2023-11-01)

Community health workers in clinical research at the example of a phase IIIb/ IV antimalarial drug trial conducted in five African countries
by: Mirjam Groger, et al.
Published: (2023-12-01)

Repurposing Antimalarial Pyronaridine as a DNA Repair Inhibitor to Exploit the Full Potential of Gold-Nanoparticle-Mediated Radiation Response
by: Nolan Jackson, et al.
Published: (2022-12-01)

Demography, maternal health and the epidemiology of malaria and other major infectious diseases in the rural department Tsamba-Magotsi, Ngounie Province, in central African Gabon
by: R. Zoleko Manego, et al.
Published: (2017-01-01)

Analysis of diagnostic test outcomes in a large loiasis cohort from an endemic region: Serological tests are often false negative in hyper-microfilaremic infections.
by: Luzia Veletzky, et al.
Published: (2024-03-01)

Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort Study.
by: María Rupérez, et al.
Published: (2016-02-01)

Adolescence as risk factor for adverse pregnancy outcome in Central Africa--a cross-sectional study.
by: Florian Kurth, et al.
Published: (2010-12-01)

Concordance of three alternative gestational age assessments for pregnant women from four African countries: A secondary analysis of the MIPPAD trial.
by: Samantha Rada, et al.
Published: (2018-01-01)

Pyronaridine-artesunate for uncomplicated falciparum malaria.
by: Nosten, F
Published: (2010)

Analysis Of Pyronaridine And Pyronaridine Tetraphosphate Using High Performance Liquid Chromatography And High Resolution Nuclear Magnetic Resonance Spectroscopy
by: Saurajen Pillay, Shubhadra Pillay
Published: (2006)

Diagnostic performance of capillary and venous blood samples in the detection of Loa loa and Mansonella perstans microfilaraemia using light microscopy.
by: Johannes Mischlinger, et al.
Published: (2021-08-01)

Quantification of the antimalarial drug pyronaridine in whole blood using LC-MS/MS - increased sensitivity resulting from reduced non-specific binding
by: Blessborn, D, et al.
Published: (2017)

Evaluation of the safety and efficacy of dihydroartemisinin–piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women: protocol of a multicentre, two-arm, randomised, placebo-controlled, superiority clinical trial (MAMAH project)
by: Michael Ramharter, et al.
Published: (2021-11-01)

Non-Invasive Malaria Detection in Sub-Saharan Africa Using a DNA-Based Sensor System
by: Trine Juul-Kristensen, et al.
Published: (2024-12-01)

Monitoring the threatened utility of malaria rapid diagnostic tests by novel high-throughput detection of Plasmodium falciparum hrp2 and hrp3 deletions: A cross-sectional, diagnostic accuracy study
by: Andrea Kreidenweiss, et al.
Published: (2019-12-01)

Boromycin has Rapid-Onset Antibiotic Activity Against Asexual and Sexual Blood Stages of Plasmodium falciparum
by: Laís Pessanha de Carvalho, et al.
Published: (2022-01-01)

Efficacy, safety, and tolerability of albendazole and ivermectin based regimens for the treatment of microfilaraemic loiasis in adult patients in Gabon: A randomized controlled assessor blinded clinical trial.
by: Rella Zoleko-Manego, et al.
Published: (2023-08-01)